Xylem
At a glance
Xylem reported 2025 revenue of $9.04B, up 5.5% from $8.56B in 2024. Over 4 years since 2021 ($5.2B), that is growth of about 14.8% a year. Operating margin was 13.5%, up from 11.3% in 2021. 2025 was the highest revenue year in this period.
In the last 12 months 4 insiders reported 2 open-market purchases ($1.1M) and 2 sales ($753K). None of the sales were flagged as 10b5-1 plan trades. The largest was a purchase of $986K by Director D Christian Koch on Oct 29, 2026. Net, insiders were buyers of $373K.
Xylem filed 11 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), officer or director change (3), other events (2) and material agreement (2). The latest officer or director change was reported on Oct 27, 2026. It reported a material agreement or a completed acquisition or disposal 2 times.
2 of the 20 investors tracked here held Xylem at the last quarter end, worth $141.8M combined. It is the largest weight for Renaissance Technologies (0.1% of its portfolio), followed by National Pension Service (Korea) (0%). Added: National Pension Service (Korea).
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $427M | $355M | $609M | $890M | $957M |
| Diluted EPS | $2.35 | $1.96 | $2.79 | $3.65 | $3.92 |
| Dividend per share | $1.12 | $1.20 | $1.32 | $1.44 | $1.60 |
Fiscal year ends Dec 31 · incorporated in IN
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined